Ron Squarer
2016
In 2016, Ron Squarer earned a total compensation of $2M as Chief Executive Officer at Array BioPharma, a 51% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $435,000 |
|---|---|
| Option Awards | $695,592 |
| Salary | $575,260 |
| Stock Awards | $226,875 |
| Other | $47,341 |
| Total | $1,980,068 |
Squarer received $695.6K in option awards, accounting for 35% of the total pay in 2016.
Squarer also received $435K in non-equity incentive plan, $575.3K in salary, $226.9K in stock awards and $47.3K in other compensation.
Rankings
In 2016, Ron Squarer's compensation ranked 4,937th out of 14,075 executives tracked by ExecPay. In other words, Squarer earned more than 64.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,937 out of 14,075 | 65th |
Division Manufacturing | 1,758 out of 5,489 | 68th |
Major group Chemicals And Allied Products | 554 out of 1,895 | 71st |
Industry group Drugs | 410 out of 1,538 | 73rd |
Industry Pharmaceutical Preparations | 325 out of 1,176 | 72nd |
Source: SEC filing on September 13, 2017.
Squarer's colleagues
We found five more compensation records of executives who worked with Ron Squarer at Array BioPharma in 2016.